REDCap Cloud’s Post

The Lancet's recent post emphasizes the ongoing global challenge of cancer, noting limited progress since the 2012 World Oncology Forum. With nearly 10 million deaths in 2022, cancer is projected to be the leading global cause of premature death. While understanding has grown, disparities persist, especially in low- and middle-income countries. The Lancet underscores the importance of local research, direction, and engagement. World Cancer Day's theme, 'Close the care gap,' highlights inequities in access. The post also addresses commercial determinants, including a manifesto aiming for a 5% smoking prevalence in the EU by 2040. Correct cancer diagnosis is essential for appropriate and effective treatment because every cancer type requires a specific treatment regimen. Treatment usually includes radiotherapy, chemotherapy and/or surgery. Determining the goals of treatment is an important first step. The primary goal is generally to cure cancer or to considerably prolong life. Improving the patient's quality of life is also an important goal. This can be achieved by support for the patient’s physical, psychosocial and spiritual well-being and palliative care in terminal stages of cancer. Some of the most common cancer types, such as breast cancer, cervical cancer, oral cancer and colorectal cancer, have high cure rates when detected early and treated according to best practices. Some cancer types, such as testicular seminoma and different types of leukaemia and lymphoma in children, also have high cure rates if appropriate treatment is provided, even when cancerous cells are present in other areas of the body. "https://lnkd.in/gQjQHe2W" #Closethecaregap #CancerResearch #WorldCancerDay 🌐🔬🎗️

𝙁𝙖𝙘𝙩𝙤𝙧𝙨 𝙖𝙛𝙛𝙚𝙘𝙩𝙞𝙣𝙜 𝙩𝙝𝙚 𝙥𝙡𝙖𝙘𝙚 𝙤𝙛 𝙙𝙚𝙖𝙩𝙝 𝙞𝙣 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨 𝙬𝙞𝙩𝙝 𝙡𝙞𝙫𝙚𝙧 𝙘𝙖𝙣𝙘𝙚𝙧 𝙞𝙣 𝘾𝙝𝙞𝙣𝙖, 2013–2020: 𝘼 𝙥𝙤𝙥𝙪𝙡𝙖𝙩𝙞𝙤𝙣-𝙗𝙖𝙨𝙚𝙙 𝙨𝙩𝙪𝙙𝙮. Factors affecting the place of death in patients with liver cancer in China, 2013–2020: A population-based study. In a recent #CancerPathogenesisAndTherapy study on #LiverCancer patient care in #China, findings underscore that #Home remains the predominant #PlaceofDeath, while #Demographic factors play a crucial role in #Hospital death. Read more,here:  https://lnkd.in/gJuqVbGS

Promoting a healthy lifestyle and reducing cancer risk factors, should be part of the educational curriculum in schools, colleges and universities, and a prioritised health and wellbeing offering in the workplace. Great article from Dr Penny Kechagioglou

A new study on two-for-one CT screening for lung cancer and cardiovascular disease not only confirms recent research showing that opportunistic screening can enhance the value of CT lung cancer scans, but also the role that lung exams can play in reducing healthcare disparities. On the down side, it shows that all the screening in the world won’t make a difference if patients don’t get appropriate follow-up. Read more at https://buff.ly/3WR6aVP #radiology #medicalimaging #lungcancer #heartdisease

As people grow older, their risk of developing cancer increases and so does their risk of becoming frail. It’s a dangerous combination, given that frailty affects up to 40 per cent of patients living with cancer, increasing their risk of both short and long-term side effects, and even death, following treatment. When a person is frail, their body has less resilience to tolerate treatments and recover, says Dr. Julie Nguyen, a gynecologic oncologist at our Juravinski Hospital and Cancer Centre. Nguyen is also a clinician-researcher who studies frailty in patients with gynecological cancers. A study co-led by Nguyen and senior researcher Dr. Maura Marcucci at the PHRI Population Health Research Institute aims to find better, more practical ways to assess frailty in patients with cancer as they go through treatment and recovery.https://https://lnkd.in/gMXt2im4 #HHSresearch #PHRI #hospital #healthcare #hamont #cancer

Recent research suggests that up to 25% of women with high-grade serous ovarian cancer, the deadliest form of the disease, could be diagnosed earlier through targeted testing and expedited specialist care. The Refining Ovarian Cancer Test Accuracy Scores (ROCkeTS) study analysed data from 24 hospitals across the UK.   ▶ Of the 1,741 patients who underwent fast-tracked ovarian cancer testing, 119 were diagnosed with high-grade serous ovarian cancer. ▶ Over 25% of these women were diagnosed at stage 1 or 2, where survival prospects are much better. Among these early-stage patients, 93% survived for more than 5 years, compared to only 13% of those diagnosed at more advanced stages.   ▶ Even when cancer had spread, most patients required only “relatively straightforward” surgery. 78 out of 119 patients had debulking surgery to remove cancer cells from the abdomen, while 36 received chemotherapy before surgery. Only 5 women did not undergo any surgical intervention.   Currently, the UK lacks a national screening program for ovarian cancer. Instead, a symptom-triggered testing approach, in place since 2011, prioritises those with symptoms including bloating, bowel changes, and abdominal pain for further testing. With around 7,500 new cases of ovarian cancer diagnosed annually in the UK, this research highlights the critical need for improved diagnostic strategies to enhance survival rates in this high-risk population.   #medicalinnovation #ovariancancer #HIPEC #CombatMedical

Recent research suggests that up to 25% of women with high-grade serous ovarian cancer, the deadliest form of the disease, could be diagnosed earlier through targeted testing and expedited specialist care. The Refining Ovarian Cancer Test Accuracy Scores (ROCkeTS) study analysed data from 24 hospitals across the UK.   ▶ Of the 1,741 patients who underwent fast-tracked ovarian cancer testing, 119 were diagnosed with high-grade serous ovarian cancer. ▶ Over 25% of these women were diagnosed at stage 1 or 2, where survival prospects are much better. Among these early-stage patients, 93% survived for more than 5 years, compared to only 13% of those diagnosed at more advanced stages.   ▶ Even when cancer had spread, most patients required only “relatively straightforward” surgery. 78 out of 119 patients had debulking surgery to remove cancer cells from the abdomen, while 36 received chemotherapy before surgery. Only 5 women did not undergo any surgical intervention.   Currently, the UK lacks a national screening program for ovarian cancer. Instead, a symptom-triggered testing approach, in place since 2011, prioritises those with symptoms including bloating, bowel changes, and abdominal pain for further testing. With around 7,500 new cases of ovarian cancer diagnosed annually in the UK, this research highlights the critical need for improved diagnostic strategies to enhance survival rates in this high-risk population.   #medicalinnovation #ovariancancer #HIPEC #CombatMedical

The NHS is revolutionising oesophageal cancer diagnosis with a simple "sponge-on-a-string" test. Developed by researchers at the University of Cambridge, this innovative approach eliminates the need for endoscopy, making the process quicker, cost-effective, and reducing waiting lists. In the pilot, 8 out of 10 patients were discharged without further testing. Small in size, but a big leap for patient care! 🔬 https://lnkd.in/eGKfJpvM #HealthcareInnovation

"According to data from Cancer Research UK, around 40% of people survive their oral cancer for 5 years or more after diagnosis. It is a rather low percentage mainly due to the delay in detecting the cancerous lesion, because in more than half of the cases the diagnosis occurs in advanced stages. It has been found that mouth cancer mortality rates will increase by 22.4% by 2030, so #prevention and #early #diagnosis in the initial stages remain the #primary objectives in the treatment of these patients. #Dental #professionals are often the ones who can detect these changes, so it is #essential to carry out #regular #oral #checkups, such as those that Lura Care carry out #free of charge in #carehomes and centres for people with #functional #diversity, two groups that often do not or cannot go to the dentist on a regular basis." See the full article at https://lnkd.in/eHjXByd2

U.S. News & World Report recently released their 10 top hospitals for cancer care. We’d like to congratulate the hospitals on this list. Of note each of the top cancer hospitals use Exergen. Read more here https://lnkd.in/g_Utfzpu... #Hospitals #Temperaturemonitoring #Accuracymatters